Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer

Bibliographic Details
Main Authors:	Keisei Okamoto, Kahori Okuyama, Naoaki Kohno, Takuya Tsugawa
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-02-01
Series:	Journal of Contemporary Brachytherapy
Subjects:	prostate cancer brachytherapy low-dose-rate intermediate risk
Online Access:	https://www.termedia.pl/Clinical-outcomes-of-low-dose-rate-brachytherapy-based-radiotherapy-for-intermediate-risk-prostate-cancer,54,39632,1,1.html

Similar Items

Low and high-dose-rate brachytherapy in combination with external beam radiotherapy for high risk prostate cancer
by: V. A. Solodkiy, et al.
Published: (2021-07-01)

High biologically effective dose radiation therapy using brachytherapy in combination with external beam radiotherapy for high-risk prostate cancer
by: Keisei Okamoto, et al.
Published: (2017-02-01)

Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radical radiotherapy
by: V. A. Solodkiy, et al.
Published: (2016-12-01)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
by: Hideya Yamazaki, et al.
Published: (2020-09-01)

LOW-DOSE RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIFFERENT INDICATIONS – DIFFERENT RESULTS
by: V. A. Biryukov
Published: (2014-07-01)

LOW-DOSE RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIFFERENT INDICATIONS – DIFFERENT RESULTS
by: V. A. Biryukov
Published: (2014-07-01)

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy
by: Michelle I. Echevarria, et al.
Published: (2016-11-01)

Salvage high-dose-rate brachytherapy for recurrent prostate cancer
by: A. D. Kaprin, et al.
Published: (2021-02-01)

Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control
by: Esther Mayrata, et al.
Published: (2021-02-01)

Correlations of post-implant regional dosimetric parameters at 24 hours and one month, with clinical results of low-dose-rate brachytherapy for localized prostate cancer
by: Eiichiro Okazaki, et al.
Published: (2017-12-01)

Salvage high dose-rate brachytherapy for local recurrence of prostate cancer after different types of radical treatment
by: V. A. Solodkiy, et al.
Published: (2019-07-01)

Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?
by: Hideya Yamazaki, et al.
Published: (2018-11-01)

Brachytherapy for prostate cancer: Comparative characteristics of procedures
by: S. V. Kanaev, et al.
Published: (2015-06-01)

Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space
by: Michael Chao, et al.
Published: (2019-02-01)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
by: Hiroaki Kunogi, et al.
Published: (2020-12-01)

Acute and late toxicities in localized prostate cancer patients treated with low-dose 125I brachytherapy (110 Gy) in combination with external beam radiation therapy versus brachytherapy alone (160 Gy)
by: Yuki Makai, et al.
Published: (2018-10-01)

Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience
by: Justin Barnes, et al.
Published: (2019-10-01)

Comparison of prostate contours between conventional stepping transverse imaging and Twister-based sagittal imaging in permanent interstitial prostate brachytherapy
by: Shogo Kawakami, et al.
Published: (2017-08-01)

Biological dose summation of intensity-modulated arc therapy and image-guided high-dose-rate interstitial brachytherapy in intermediate- and high-risk prostate cancer
by: Georgina Fröhlich, et al.
Published: (2020-06-01)

Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival
by: Sophie Robin, et al.
Published: (2021-08-01)

Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
by: Finbar Slevin, et al.
Published: (2020-07-01)

Small cell carcinoma of the prostate after low-dose-rate brachytherapy: a case report
by: Eva Van Bos, et al.
Published: (2020-10-01)

High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses – 14 years of single-centre experience
by: Carlo Pietro Soatti, et al.
Published: (2020-12-01)

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
by: Hideya Yamazaki, et al.
Published: (2021-04-01)

Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer
by: Hideyasu Tsumura, et al.
Published: (2016-04-01)

High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
by: Hideya Yamazaki, et al.
Published: (2018-09-01)

Use of deformable image registration techniques to estimate dose to organs at risk following prostate external beam radiation therapy and high-dose-rate brachytherapy
by: Marie Vozzo, et al.
Published: (2021-02-01)

Focal application of low-dose-rate brachytherapy for prostate cancer: a pilot study
by: S. Sara Mahdavi, et al.
Published: (2017-06-01)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
by: Ting Martin Ma, et al.
Published: (2020-12-01)

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
by: Toru Matsugasumi, et al.
Published: (2021-06-01)

Utilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?
by: Joseph Safdieh, et al.
Published: (2016-08-01)

Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy
by: Keiko Nemoto Murofushi, et al.
Published: (2021-02-01)

Evaluation of a mobile C‐arm cone‐beam CT in interstitial high‐dose‐rate prostate brachytherapy treatment planning
by: Mario Djukelic, et al.
Published: (2019-06-01)

Efficacy and Safety of High-Dose-Rate Brachytherapy of Single Implant with Two Fractions Combined with External Beam Radiotherapy for Hormone-Naïve Localized Prostate Cancer
by: Yasutaka Noda, et al.
Published: (2011-09-01)

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer
by: Yasushi Nakai, et al.
Published: (2019-09-01)

Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer
by: D. M. Yagudaev, et al.
Published: (2018-07-01)

Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer
by: Nobumichi Tanaka, et al.
Published: (2017-08-01)

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center
by: Bengt Johansson, et al.
Published: (2021-05-01)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
by: Jessika A. Contreras, et al.
Published: (2015-02-01)

Dosimetry of permanent interstitial prostate brachytherapy for an intraoperative procedure, using O-arm based CT and TRUS
by: Hiromichi Ishiyama, et al.
Published: (2016-02-01)

Cannot write session to /tmp/vufind_sessions/sess_1dl15995jg1p1vphf8gl7haitv